Literature DB >> 11681713

Functional properties of the rat phosphatase 1alpha promoter.

B Linck1, P Boknik, J Knapp, K Kikuchi, H Lüss, F U Müller, K Nomoto, J Neumann, W Schmitz.   

Abstract

The aim of this study was to investigate the functional properties of the promoter of the protein phosphatase 1alpha catalytic subunit. Luciferase plasmids with different fragments of the rat catalytic subunit of the protein phosphatase 1alpha promoter ranging from -3.7 kbp to -59 bp were transiently transfected into cells by the calcium-phosphate precipitation method. The promoter activity was determined in the absence and presence of inotropic agents which influencing the cAMP-depending pathway. The basal transcriptional activity decreased at fragment -124 bp and shorter fragments. To identify regions of regulatory importance we investigated the cAMP-dependent influence on the transcriptional activity. Stimulation of the complete promoter region with forskolin (1-100 microM) for 6 h led to a concentration-dependent decrease of transcriptional activity. Moreover, regions shorter than 3.7 kbp were inhibited by forskolin (10 microM). Short time stimulation (10 min) with forskolin (10 microM) increased the transcriptional activity of only the 3.7 kbp fragment. The effects were antagonized by Rp-cAMPS, a specific antagonist of protein kinase A, indicating cAMP-dependent effects. The results provide evidence for cAMP-dependent regulation of the protein phosphatase 1alpha promotor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11681713     DOI: 10.1023/a:1017926713989

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

Review 1.  Effects of serine/threonine protein phosphatases on ion channels in excitable membranes.

Authors:  S Herzig; J Neumann
Journal:  Physiol Rev       Date:  2000-01       Impact factor: 37.312

Review 2.  Alterations of calcium-regulatory proteins in heart failure.

Authors:  G Hasenfuss
Journal:  Cardiovasc Res       Date:  1998-02       Impact factor: 10.787

3.  Increase in myocardial Gi-proteins in heart failure.

Authors:  J Neumann; W Schmitz; H Scholz; L von Meyerinck; V Döring; P Kalmar
Journal:  Lancet       Date:  1988-10-22       Impact factor: 79.321

4.  The effect of the protein phosphatases inhibitor cantharidin on beta-adrenoceptor-mediated vasorelaxation.

Authors:  J Knapp; P Bokník; B Linck; H Lüss; F U Müller; P Nacke; J Neumann; U Vahlensieck; W Schmitz
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

5.  Molecular cloning and analysis of the 5'-flanking region of the rat PP1 alpha gene.

Authors:  K Nomoto; N Shibata; K Kitamura; Y Mizuno; K Kikuchi
Journal:  Biochim Biophys Acta       Date:  1996-12-11

Review 6.  Serine/threonine protein phosphatases.

Authors:  S Wera; B A Hemmings
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

7.  In vivo beta-adrenergic stimulation leads to biphasic regulation of Gi alpha-2 gene transcriptional activity in rat heart.

Authors:  F U Müller; T Eschenhagen; A Reidemeister; W Schmitz; H Scholz
Journal:  J Mol Cell Cardiol       Date:  1994-07       Impact factor: 5.000

8.  cAMP response element binding protein is expressed and phosphorylated in the human heart.

Authors:  F U Müller; P Bokník; A Horst; J Knapp; B Linck; W Schmitz; U Vahlensieck; M Böhm; M C Deng; H H Scheld
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

9.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

10.  Expression of the gene encoding transcription factor cyclic adenosine 3',5'-monophosphate (cAMP) response element-binding protein (CREB): regulation by follicle-stimulating hormone-induced cAMP signaling in primary rat Sertoli cells.

Authors:  W H Walker; L Fucci; J F Habener
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.